Literature DB >> 2691173

Capillary permeability and extracellular fluid volumes in pregnancy-induced hypertension.

M A Brown1, V C Zammit, S A Lowe.   

Abstract

1. Capillary permeability was determined by the disappearance rate of Evans Blue dye from plasma in healthy non-pregnant women, normal third-trimester primigravidae and primigravidae with pregnancy-induced hypertension. 2. Extracellular fluid volume was determined from the disappearance curves of injected mannitol in the same subjects and the plasma volume was measured by the Evans Blue dye dilution technique. 3. In normal pregnancy capillary permeability was not altered from that of non-pregnant subjects. Although extracellular fluid volume and plasma volume were increased in normal pregnant compared with non-pregnant women, the distribution of fluid between plasma volume and interstitial fluid volume was unaltered. 4. Women with established pregnancy-induced hypertension had a more rapid Evans Blue disappearance rate and a lower plasma volume than normal pregnant women, independent of the presence of proteinuria. Maternal plasma volume correlated positively and significantly with fetal birth weight in women with pregnancy-induced hypertension, emphasizing the important relationship between maternal plasma volume and fetal outcome. 5. The increased capillary permeability in women with pregnancy-induced hypertension was associated with a reduction in the plasma volume/interstitial fluid volume ratio but a normal extracellular fluid volume, suggesting that the reduced plasma volume did not result from sodium loss but rather from a redistribution of the total extracellular fluid volume. These changes did not differ significantly in subgroups with and without oedema.

Entities:  

Mesh:

Year:  1989        PMID: 2691173     DOI: 10.1042/cs0770599

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  16 in total

Review 1.  Quantification of renal haemodynamics with radionuclides.

Authors:  A M Peters
Journal:  Eur J Nucl Med       Date:  1991

2.  Involvement of the Bufadienolides in the Detection and Therapy of the Acute Respiratory Distress Syndrome.

Authors:  Mir M K Abbas; B Patel; Q Chen; W Jiang; B Moorthy; R Barrios; J B Puschett
Journal:  Lung       Date:  2017-03-04       Impact factor: 2.584

3.  Chymotrypsin-like protease (chymase) mediates endothelial activation by factors derived from preeclamptic placentas.

Authors:  J Steven Alexander; Lynn J Groome
Journal:  Reprod Sci       Date:  2009-06-03       Impact factor: 3.060

4.  Massive ascites and bilateral pleural effusion causing respiratory embarrassment in a postnatal case of severe preeclampsia.

Authors:  Reema Kumar; Madhusudan Dey
Journal:  Med J Armed Forces India       Date:  2012-11-30

5.  Renin-Angiotensin-Aldosterone Profiles in Pregnant Women With Chronic Hypertension.

Authors:  Line Malha; Cristina P Sison; Geraldine Helseth; Jean E Sealey; Phyllis August
Journal:  Hypertension       Date:  2018-06-25       Impact factor: 10.190

6.  Modern management of eclampsia.

Authors:  O Salha; J J Walker
Journal:  Postgrad Med J       Date:  1999-02       Impact factor: 2.401

7.  Severe hyponatraemia associated with pre-eclampsia.

Authors:  Breffini Anglim; Kirk Levins; Neidin Bussmann; Mendinaro Imcha
Journal:  BMJ Case Rep       Date:  2016-08-24

8.  Massive Ascites and Pleural Effusion in Preeclampsia.

Authors:  Sezen Bozkurt Koseoglu; Ruya Deveer; Aysun Camuzcuoglu; Burcu Kasap; Hakan Camuzcuoglu
Journal:  J Clin Diagn Res       Date:  2017-02-01

Review 9.  The kinetic basis of glomerular filtration rate measurement and new concepts of indexation to body size.

Authors:  A M Peters
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-10-31       Impact factor: 9.236

10.  Placenta-derived chymotrypsin-like protease (CLP) disturbs endothelial junctional structure in preeclampsia.

Authors:  Yang Gu; David F Lewis; J Steven Alexander; Yuping Wang
Journal:  Reprod Sci       Date:  2009-01-06       Impact factor: 3.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.